Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers. (December 2016)

Record Type:: Journal Article
Title:: Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers. (December 2016)
Main Title:: Entrectinib, a highly potent pan-Trk, ROS1, and ALK inhibitor, has broad-spectrum, histology-agnostic anti-tumor activity in molecularly defined cancers
Authors:: Wei, G.
Patel, R.
Walsh, C.
Barrera, M.
Fagan, P.
Murphy, D.
Christiansen, J.
Shoemaker, R.
Hornby, Z.
Li, G.G.
Abstract:
Is Part Of:: European journal of cancer. Volume 69(2016)supplement 1
Journal:: European journal of cancer
Issue:: Volume 69(2016)supplement 1
Issue Display:: Volume 69, Issue 2016 (2016)
Year:: 2016
Volume:: 69
Issue:: 2016
Issue Sort Value:: 2016-0069-2016-0000
Page Start:: S33
Page End:
Publication Date:: 2016-12
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(16)32678-8 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2630.xml